Company news
Kyntra Bio, Inc. (NASDAQ:KYNB) news
Kyntra Bio, Inc. news releases on 6ix. Latest, Oct 1, 2026: Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
Press releases & updates
Kyntra Bio Appoints Andrew E. Singer, MBA to its Board of Directors
October 1, 2026
Kyntra Bio to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 2, 2026
Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation
August 31, 2026
Kyntra Bio Reports Second Quarter 2026 Financial Results and Provides Business Update
August 13, 2026
Kyntra Bio to Report Second Quarter 2026 Financial Results
August 6, 2026
Kyntra Bio Presents New Roxadustat Data on Improvements in Transfusion Independence Regardless of Ring Sideroblast Status in Patients with Anemia due to Lower-Risk Myelodysplastic Syndromes
June 10, 2026
Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
May 10, 2026
Kyntra Bio to Report First Quarter 2026 Financial Results
May 4, 2026
Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference
April 8, 2026
Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 16, 2026
Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results
March 9, 2026
Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026
February 23, 2026
Kyntra Bio to Participate in Upcoming Investor Conferences
February 17, 2026